Correlation Between Vodafone Group and SkinBioTherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vodafone Group and SkinBioTherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vodafone Group and SkinBioTherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vodafone Group PLC and SkinBioTherapeutics PLC, you can compare the effects of market volatilities on Vodafone Group and SkinBioTherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vodafone Group with a short position of SkinBioTherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vodafone Group and SkinBioTherapeutics.

Diversification Opportunities for Vodafone Group and SkinBioTherapeutics

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vodafone and SkinBioTherapeutics is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Vodafone Group PLC and SkinBioTherapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SkinBioTherapeutics PLC and Vodafone Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vodafone Group PLC are associated (or correlated) with SkinBioTherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SkinBioTherapeutics PLC has no effect on the direction of Vodafone Group i.e., Vodafone Group and SkinBioTherapeutics go up and down completely randomly.

Pair Corralation between Vodafone Group and SkinBioTherapeutics

Assuming the 90 days trading horizon Vodafone Group PLC is expected to under-perform the SkinBioTherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Vodafone Group PLC is 2.96 times less risky than SkinBioTherapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The SkinBioTherapeutics PLC is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,738  in SkinBioTherapeutics PLC on August 30, 2024 and sell it today you would lose (150.00) from holding SkinBioTherapeutics PLC or give up 8.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vodafone Group PLC  vs.  SkinBioTherapeutics PLC

 Performance 
       Timeline  
Vodafone Group PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vodafone Group PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Vodafone Group is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
SkinBioTherapeutics PLC 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SkinBioTherapeutics PLC are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, SkinBioTherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vodafone Group and SkinBioTherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vodafone Group and SkinBioTherapeutics

The main advantage of trading using opposite Vodafone Group and SkinBioTherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vodafone Group position performs unexpectedly, SkinBioTherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SkinBioTherapeutics will offset losses from the drop in SkinBioTherapeutics' long position.
The idea behind Vodafone Group PLC and SkinBioTherapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum